Factors influencing the efficacy of nutritional interventions on muscle mass in older adults: a systematic review and meta-analysis
Reads0
Chats0
TLDR
Several nutritional interventions could be effective to improve muscle mass measures in older adults because of the substantial variability of the intervention factors among studies, the optimum profile is yet to be established.Abstract:
CONTEXT: Nutritional interventions stimulate muscle protein synthesis in older adults. To optimize muscle mass preservation and gains, several factors, including type, dose, frequency, timing, duration, and adherence have to be considered. OBJECTIVE: This systematic review and meta-analysis aimed to summarize these factors influencing the efficacy of nutritional interventions on muscle mass in older adults. DATA SOURCES: A systematic search was performed using the electronic databases MEDLINE, Embase, CINAHL, Cochrane Central Register of Controlled Trials, and SPORTDiscus from inception date to November 22, 2017, in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Inclusion criteria included randomized controlled trials, mean or median age ≥65 years, and reporting muscle mass at baseline and postintervention. Exclusion criteria included genetically inherited diseases, anabolic drugs or hormone therapies, neuromuscular electrical stimulation, chronic kidney disease, kidney failure, neuromuscular disorders, and cancer. DATA EXTRACTION: Extracted data included study characteristics (ie, population, sample size, age, sex), muscle mass measurements (ie, method, measure, unit), effect of the intervention vs the control group, and nutritional intervention factors (ie, type, composition, dose, duration, frequency, timing, and adherence). DATA ANALYSIS: Standardized mean differences and 95%CIs were calculated from baseline to postintervention. A meta-analysis was performed using a random-effects model and grouped by the type of intervention. CONCLUSIONS: Twenty-nine studies were included, encompassing 2255 participants (mean age, 78.1 years; SD, 2.22). Amino acids, creatine, β-hydroxy-β-methylbutyrate, and protein with amino acids supplementation significantly improved muscle mass. No effect was found for protein supplementation alone, protein and other components, and polyunsaturated fatty acids. High interstudy variability was observed regarding the dose, duration, and frequency, coupled with inconsistency in reporting timing and adherence. Overall, several nutritional interventions could be effective to improve muscle mass measures in older adults. Because of the substantial variability of the intervention factors among studies, the optimum profile is yet to be established. SYSTEMATIC REVIEW REGISTRATION: PROSPERO registration no. CRD42018111306.read more
Citations
More filters
Journal ArticleDOI
Muscle mass, strength, and physical performance predicting activities of daily living: a meta-analysis
Daniel X.M. Wang,Jessica Yao,Yasar Zirek,Esmee M. Reijnierse,Andrea B. Maier,Andrea B. Maier +5 more
TL;DR: In this article, a systematic review and meta-analysis was conducted to determine if muscle measures are predictive of ADL and IADL in older populations and found that low muscle mass was positively associated with ADL dependency in 5/9 articles and 5/5 for IADl dependency.
Journal Article
Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort
Astrid Y. Bijlsma,Carel G. M. Meskers,Carolina H. Y. Ling,Marco V. Narici,Susan Kurrle,Ian D. Cameron,Rudi G. J. Westendorp,Andrea B. Maier +7 more
TL;DR: It is concluded that the prevalence of sarcopenia is highly dependent on the applied diagnostic criteria and it is necessary to reach a consensus on the definition of sarc Openia in order to make studies comparable and for implementation in clinical care.
Journal ArticleDOI
Prevalence of sarcopenia as a comorbid disease: A systematic review and meta-analysis.
Jacob Pacifico,Milou A.J. Geerlings,Esmee M. Reijnierse,Christina Phassouliotis,Wen Kwang Lim,Andrea B. Maier,Andrea B. Maier +6 more
TL;DR: Sarcopenia is highly prevalent in individuals with CVD, dementia, diabetes mellitus and respiratory disease and is stratified by disease, definition of sarcopenia and continent.
Journal ArticleDOI
Systematic review and meta‐analysis of protein intake to support muscle mass and function in healthy adults
TL;DR: In this article , a systematic review, meta-analysis, and meta-regression were performed to determine if increasing daily protein ingestion contributes to gaining lean body mass (LBM), muscle strength, and physical/functional test performance in healthy subjects.
Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways
Rafael Barreto,Giorgia Mandili,Frank A. Witzmann,Francesco Novelli,Teresa A. Zimmers,Andrea Bonetto +5 more
TL;DR: The results suggest that both cancer and chemotherapy contribute to muscle loss by activating common signaling pathways, and the undertaking of combination strategies that aim to both counteract tumor growth and reduce chemotherapy side effects are supported.
References
More filters
Journal ArticleDOI
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
TL;DR: Moher et al. as mentioned in this paper introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses, which is used in this paper.
Journal Article
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
TL;DR: The QUOROM Statement (QUality Of Reporting Of Meta-analyses) as mentioned in this paper was developed to address the suboptimal reporting of systematic reviews and meta-analysis of randomized controlled trials.
Journal Article
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement [in Spanish]
David Moher,Alessandro Liberati,Jennifer Tetzlaff,Douglas G. Altman,Gerd Antes,David C. Atkins,Virginia Barbour,N Barrowman,Jesse A. Berlin,J Clark,Mike Clarke,Deborah J. Cook,Roberto D'Amico,Jonathan J Deeks,Philip J. Devereaux,Kay Dickersin,M Egger,E Ernst,P C Gøtzsche,Jeremy M. Grimshaw,G Guyatt,Julian P T Higgins,Ioannidis Jpa.,Jos Kleijnen,Tom Lang,N Magrini,D McNamee,Lorenzo Moja,C Mulrow,M Napoli,Andrew D Oxman,B Pham,Drummond Rennie,Margaret Sampson,Kenneth F. Schulz,Paul G. Shekelle,David Tovey,Peter Tugwell +37 more
Journal ArticleDOI
The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
Julian P T Higgins,Douglas G. Altman,Peter C Gøtzsche,Peter Jüni,David Moher,Andrew D Oxman,Jelena Savović,Kenneth F. Schulz,Laura Weeks,Jonathan A C Sterne +9 more
TL;DR: The Cochrane Collaboration’s tool for assessing risk of bias aims to make the process clearer and more accurate.
Journal ArticleDOI
Sarcopenia: European consensus on definition and diagnosis Report of the European Working Group on Sarcopenia in Older People
Alfonso J. Cruz-Jentoft,Jean-Pierre Baeyens,Jürgen M. Bauer,Yves Boirie,Tommy Cederholm,Francesco Landi,Finbarr C. Martin,Jean-Pierre Michel,Yves Rolland,Stéphane M. Schneider,Eva Topinkova,Maurits Vandewoude,Mauro Zamboni +12 more
TL;DR: The European Working Group on Sarcopenia in Older People (EWGSOP) developed a practical clinical definition and consensus diagnostic criteria for age-related sarcopenia as discussed by the authors.